Department of Biological Sciences, Louisiana State University - Shreveport, One University Place, Shreveport, LA 71115, USA.
Diagn Pathol. 2012 Jun 12;7:66. doi: 10.1186/1746-1596-7-66.
Genomic tumor information, such as identification of amplified oncogenes, can be used to plan treatment. The two sources of a brain tumor that are commonly available include formalin-fixed, paraffin-embedded (FFPE) sections from the small diagnostic biopsy and the ultrasonic surgical aspiration that contains the bulk of the tumor. In research centers, frozen tissue of a brain tumor may also be available. This study compared ultrasonic surgical aspiration and FFPE specimens from the same brain tumors for retrieval of DNA and molecular assessment of amplified oncogenes.
Surgical aspirations were centrifuged to separate erythrocytes from the tumor cells that predominantly formed large, overlying buffy coats. These were sampled to harvest nuclear pellets for DNA purification. Four glioblastomas, 2 lung carcinoma metastases, and an ependymoma were tested. An inexpensive PCR technique, multiplex ligation-dependent probe amplification (MLPA), quantified 79 oncogenes using 3 kits. Copy number (CN) results were normalized to DNA from non-neoplastic brain (NB) in calculated ratios, [tumor DNA]/[NB DNA]. Bland-Altman and Spearman rank correlative comparisons were determined. Regression analysis identified outliers.
Purification of DNA from ultrasonic surgical aspirations was rapid (<3 days) versus FFPE (weeks) and yielded greater amounts in 6 of 7 tumors. Gene amplifications up to 15-fold corresponded closely between ultrasonic aspiration and FFPE assays in Bland-Altman analysis. Correlation coefficients ranged from 0.71 to 0.99 using 3 kit assays per tumor. Although normalized CN ratios greater than 2.0 were more numerous in FFPE specimens, some were found only in the ultrasonic surgical aspirations, consistent with tumor heterogeneity. Additionally, CN ratios revealed 9 high-level (≥ 6.0) gene amplifications in FFPE of which 8 were also detected in the ultrasonic aspirations at increased levels. The ultrasonic aspiration levels of these amplified genes were also greater than 6.0 CN ratio, except in one case (3.53 CN ratio). Ten of 17 mid-level (≥3.0 & <6.0 CN ratio) amplifications detected in FFPE were also detected as being increased (≥ 2.0 CN ratio) in the aspirations.
Buffy coats of centrifuged ultrasonic aspirations contained abundant tumor cells whose DNA permitted rapid, multiplex detection of high-level oncogene amplifications that were confirmed in FFPE.
http://www.diagnosticpathology.diagnomx.eu/vs/1883718801686466.
基因组肿瘤信息,如识别扩增的癌基因,可以用于治疗计划。大脑肿瘤的两个常见来源包括从小诊断性活检获得的福尔马林固定、石蜡包埋(FFPE)切片和包含大部分肿瘤的超声手术抽吸物。在研究中心,也可能有脑肿瘤的冷冻组织。本研究比较了同一脑肿瘤的超声手术抽吸物和 FFPE 标本,以获取 DNA 并对扩增的癌基因进行分子评估。
手术抽吸物离心以分离红细胞与主要形成大的、覆盖性的血涂片的肿瘤细胞。从这些细胞中采样收获核沉淀以纯化 DNA。对 4 个胶质母细胞瘤、2 个肺癌转移瘤和 1 个室管膜瘤进行了测试。使用 3 种试剂盒,一种廉价的 PCR 技术,多重连接依赖性探针扩增(MLPA),定量了 79 个癌基因。拷贝数(CN)结果用计算比值(肿瘤 DNA/非肿瘤性脑(NB)DNA)进行归一化。进行了 Bland-Altman 和 Spearman 秩相关比较。回归分析确定了离群值。
从超声手术抽吸物中纯化 DNA 速度很快(<3 天),而 FFPE 则需要数周(数周),7 个肿瘤中有 6 个肿瘤的 DNA 产量更高。在 Bland-Altman 分析中,超声抽吸物和 FFPE 检测之间的基因扩增高达 15 倍。使用 3 种试剂盒对每个肿瘤进行检测,相关系数范围为 0.71 至 0.99。虽然 FFPE 标本中的归一化 CN 比值大于 2.0 的情况更多,但在一些情况下仅在超声手术抽吸物中发现,这与肿瘤异质性一致。此外,CN 比值揭示了 9 个高水平(≥6.0)的基因扩增,其中 8 个在超声抽吸物中也以更高水平检测到。这些扩增基因的超声抽吸物水平也大于 6.0 的 CN 比值,除了 1 个病例(3.53 CN 比值)。在 FFPE 中检测到的 17 个中水平(≥3.0 且<6.0 CN 比值)扩增中有 10 个也被检测为增加(≥2.0 CN 比值)在抽吸物中。
离心超声抽吸的血涂片富含肿瘤细胞,其 DNA 允许快速、多重检测高水平的癌基因扩增,这些扩增在 FFPE 中得到了证实。